Project Grant R43MH125691

MOBILE TECHNOLOGY FOR REDUCING AND PREVENTING ADOLESCENT SUICIDE - ABSTRACT SUICIDE IS A TOP TWO CAUSE OF DEATH IN THE US FOR ADOLESCENTS AND SUICIDE RATES AMONG YOUTH HAVE STEADILY INCREASED. DESPITE THIS, THERE IS A PAUCITY OF RESEARCH ON MOBILE TECHNOLOGY DESIGNED TO REDUCE SUICIDE ATTEMPTS AMONG YOUTH. IN THIS PHASE I SBIR APPLICATION OUI THERAPEUTICS, LLC PROPOSES A PROJECT TO: 1) CREATE A BETA VERSION OF AVIVA-Y FOR YOUTH (AGES 13 - 17); AND 2) TO TEST THE FEASIBILITY AND ACCEPTABILITY OF THE BETA VERSION OF AVIVA-Y IN A SINGLE-GROUP, OPEN-LABEL TRIAL. SUCCESSFUL EXECUTION OF THE GOALS OF THIS PHASE I PROJECT WILL GENERATE A VERSION OF AVIVA-Y THAT IS READY TO BE TESTED FOR EFFICACY WITH STABILIZED PATIENTS IN A CLINICAL TRIAL. IN THE LONG TERM, THIS PROJECT WILL HAVE A BENEFICIAL IMPACT ON THE FIELD OF YOUTH SUICIDE PREVENTION THROUGH THE DEVELOPMENT OF MOBILE TECHNOLOGY DESIGNED TO ADVANCE THE DELIVERY AND DISSEMINATION OF EFFECTIVE INTERVENTIONS.